BioCentury | Jul 14, 2003
Company News

Genicon, Invitrogen deal

...which were launched last year. IVGN retains exclusive commercialization rights to other RLS research uses. Genicon Sciences Corp....
BioCentury | May 12, 2003
Company News

Inimex, Genicon deal

...to develop gene expression-based tools for its RLS technology. Inimex Pharmaceuticals Inc. , Vancouver, B.C. Genicon Sciences Corp....
BioCentury | Feb 10, 2003
Company News

Genicon, Qiagen sales and marketing update

...received exclusive distribution rights to RLS from Genicon in 2001 (see BioCentury, Aug. 13, 2001). Genicon Sciences Corp....
BioCentury | Aug 5, 2002
Company News

Genicon sales and marketing update

...other assays. The product uses Genicon’s RLS (resonance light scattering) signal generation and detection technology. Genicon Sciences Corp....
BioCentury | Dec 24, 2001
Company News

Genicon, Becton Dickinson & Co. Inc. deal

...manufacturing, distributing and marketing the integrated assay system. BD Biosciences also may market the assays. Genicon Sciences Corp....
BioCentury | Nov 5, 2001
Company News

Genicon, The Genomics Institute of the Novartis Research Foundation deal

...technologies for use in developing RLS for murine antibody arrays and protein microarray tool kits. Genicon Sciences Corp....
BioCentury | Oct 15, 2001
Company News

Qiagen, Kreatech Biotechnology B.V. sales and marketing update

QIA received from Kreatech an exclusive license to its Universal Linkage System (ULS) labeling technologies and products to use in combination with QIA's resonance light scattering microarray toolkit products, which QIA licensed from Genicon Sciences...
BioCentury | Aug 13, 2001
Company News

Qiagen, Bayer, Genicon deal

...purification consumables. Qiagen N.V. (NMarkt:QIA; QGENF), Venlo, The Netherlands Bayer AG (FSE:BAYG; BAYZY), Leverkusen, Germany Genicon Sciences Corp....
BioCentury | May 21, 2001
Company News

Oasis scientific advisory board update

...Biosciences Inc., San Diego, Calif. Business: Functional genomics Appointed: David Kohne, chief scientific consultant to Genicon Sciences Corp. WIR...
BioCentury | May 7, 2001
Clinical News

Resonance Light Scattering regulatory update

...particles as labels for detection of analytes in a variety of biological assays and formats. Genicon Sciences Corp....
Items per page:
1 - 10 of 12
BioCentury | Jul 14, 2003
Company News

Genicon, Invitrogen deal

...which were launched last year. IVGN retains exclusive commercialization rights to other RLS research uses. Genicon Sciences Corp....
BioCentury | May 12, 2003
Company News

Inimex, Genicon deal

...to develop gene expression-based tools for its RLS technology. Inimex Pharmaceuticals Inc. , Vancouver, B.C. Genicon Sciences Corp....
BioCentury | Feb 10, 2003
Company News

Genicon, Qiagen sales and marketing update

...received exclusive distribution rights to RLS from Genicon in 2001 (see BioCentury, Aug. 13, 2001). Genicon Sciences Corp....
BioCentury | Aug 5, 2002
Company News

Genicon sales and marketing update

...other assays. The product uses Genicon’s RLS (resonance light scattering) signal generation and detection technology. Genicon Sciences Corp....
BioCentury | Dec 24, 2001
Company News

Genicon, Becton Dickinson & Co. Inc. deal

...manufacturing, distributing and marketing the integrated assay system. BD Biosciences also may market the assays. Genicon Sciences Corp....
BioCentury | Nov 5, 2001
Company News

Genicon, The Genomics Institute of the Novartis Research Foundation deal

...technologies for use in developing RLS for murine antibody arrays and protein microarray tool kits. Genicon Sciences Corp....
BioCentury | Oct 15, 2001
Company News

Qiagen, Kreatech Biotechnology B.V. sales and marketing update

QIA received from Kreatech an exclusive license to its Universal Linkage System (ULS) labeling technologies and products to use in combination with QIA's resonance light scattering microarray toolkit products, which QIA licensed from Genicon Sciences...
BioCentury | Aug 13, 2001
Company News

Qiagen, Bayer, Genicon deal

...purification consumables. Qiagen N.V. (NMarkt:QIA; QGENF), Venlo, The Netherlands Bayer AG (FSE:BAYG; BAYZY), Leverkusen, Germany Genicon Sciences Corp....
BioCentury | May 21, 2001
Company News

Oasis scientific advisory board update

...Biosciences Inc., San Diego, Calif. Business: Functional genomics Appointed: David Kohne, chief scientific consultant to Genicon Sciences Corp. WIR...
BioCentury | May 7, 2001
Clinical News

Resonance Light Scattering regulatory update

...particles as labels for detection of analytes in a variety of biological assays and formats. Genicon Sciences Corp....
Items per page:
1 - 10 of 12